SPY424.31+0.70 0.17%
DIA345.12+0.14 0.04%
IXIC14,069.42+49.09 0.35%

BRIEF-Eli Lilly And MiNA Therapeutics Announce saRNA Research Collaboration

05/11/2021 08:28
BRIEF-Eli Lilly And MiNA Therapeutics Announce saRNA Research Collaboration

- Eli Lilly and Co LLY.N:

  • LILLY AND MINA THERAPEUTICS ANNOUNCE SARNA RESEARCH COLLABORATION

  • ELI LILLY AND CO - MINA WILL RECEIVE A $25 MILLION UPFRONT PAYMENT

  • ELI LILLY AND CO - MINA ELIGIBLE TO RECEIVE POTENTIAL DEVELOPMENT AND COMMERCIALIZATION MILESTONES UP TO A TOTAL OF $245 MILLION PER TARGET

  • ELI LILLY - MINA WILL UTILIZE SARNA PLATFORM TO RESEARCH UP TO 5 TARGETS SELECTED BY CO TO ADDRESS DISEASES ACROSS CO'S KEY THERAPEUTIC FOCUS AREAS

  • ELI LILLY AND CO - THERE WILL BE NO CHANGE TO LILLY'S 2021 NON-GAAP EPS GUIDANCE AS A RESULT OF DEAL

  • ELI LILLY AND CO - MINA ELIGIBLE TO RECEIVE TIERED ROYALTIES FROM LOW-SINGLE TO LOW-DOUBLE DIGITS ON PRODUCT SALES RESULTING FROM COLLABORATION

Source text for Eikon: ID:nPn5QFgwFa

Further company coverage: LLY.N


(([email protected];))